Beata Sas-Korczynska
Overview
Explore the profile of Beata Sas-Korczynska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grela-Wojewoda A, Puskulluoglu M, Sas-Korczynska B, Zemelka T, Pacholczak-Madej R, Wysocki W, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884413
Trastuzumab-induced cardiotoxicity (TIC) can lead to early treatment discontinuation. The aim of this study was to evaluate: N-terminal brain natriuretic peptide (NT-proBNP), creatine kinase-MB (CK-MB), myoglobin, and selected biochemical and...
2.
Grela-Wojewoda A, Niemiec J, Sas-Korczynska B, Zemelka T, Puskulluoglu M, Wysocki W, et al.
Pol Arch Intern Med
. 2022 Jan;
132(4).
PMID: 35089680
Introduction: Recently, the prognosis of patients with HER2‑positive breast cancer (BC) has improved significantly owing to the use of combined treatment modalities. However, systemic treatment is as-sociated with increased risk...
3.
Kepka L, Socha J, Sas-Korczynska B
J Thorac Dis
. 2021 Jun;
13(5):3269-3278.
PMID: 34164219
Management of brain metastases (BM) from small-cell lung cancer (SCLC) is complex and not supported by a strong evidence from prospective clinical trials. Owing to the different clinical and pathological...
4.
Sas-Korczynska B, Rucinska M
J Thorac Dis
. 2021 Jun;
13(5):3246-3257.
PMID: 34164217
The incidence of brain metastases (BM) is estimated between 20% and 40% of patients with solid cancer. The most common cause of this failure is lung cancer, and in locally...
5.
Wysocka J, Adamczyk A, Kruczak A, Niemiec J, Sas-Korczynska B
Pol J Pathol
. 2020 Jul;
71(2):107-119.
PMID: 32729301
Apocrine carcinoma is a very rare type of breast cancer, which represents 0.5-4% of all breast cancers. The aim of the study was to analyze biological and clinical features of ...
6.
Stock M, Gora J, Perpar A, Georg P, Lehde A, Kragl G, et al.
Acta Oncol
. 2019 Aug;
58(12):1720-1730.
PMID: 31393203
A collaborative network between proton therapy (PT) centres in Trento in Italy, Poland, Austria, Czech Republic and Sweden (IPACS) was founded to implement trials and harmonize PT. This is the...
7.
Rudnicki W, Heinze S, Niemiec J, Kojs Z, Sas-Korczynska B, Hendrick E, et al.
Eur Radiol
. 2019 May;
29(11):6220-6226.
PMID: 31089850
Objectives: Contrast-enhanced spectral mammography (CESM) is a novel method for breast cancer detection. The aim of this study is to check if there is a possibility of quantitative assessment of...
8.
Sas-Korczynska B, Reinfuss M, Mitus J, Pluta E, Patla A, Walasek T
Rep Pract Oncol Radiother
. 2018 Aug;
23(5):402-406.
PMID: 30147451
Objectives: Radiotherapy in patients with sinonasal mucosal melanoma (SNMM) was given as alternative treatment to surgery in cases with advanced, inoperable tumors or those not eligible for surgery. We presented...
9.
Kurzynski M, Mitus J, Kolodziej-Rzepa M, Sas-Korczynska B
Ginekol Pol
. 2018 Aug;
89(5):235-239.
PMID: 30084474
Objectives: Cancer morbidity rates have been increasing steadily. A longer lifespan and easier access to modern diagnostic and therapeutic methods are the main reasons for the growing number of cancer...
10.
Romanowska-Dixon B, Markiewicz A, Sas-Korczynska B, Medon D, Walasek T
Klin Oczna
. 2018 Jun;
118(4):289-92.
PMID: 29911361
Purpose: The aim of the research was to evaluate of intraocular complications after proton beam therapy of choroidal melanomas Material And Methods: A total 105 patients (48 female and 57...